期刊文献+
任意字段
题名或关键词
题名
关键词
文摘
作者
第一作者
机构
刊名
分类号
参考文献
作者简介
基金资助
栏目信息

阿霉素和依托泊苷为主的联合化疗方案治疗外周T细胞淋巴瘤 被引量：5

原文传递
导出
摘要 外周T细胞淋巴瘤-非特指型（peripheral T-cell lymphoma-unspecified，PTCL-U）是起源于胸腺后T淋巴细胞的一大类恶性肿瘤，具有明显的异质性。PTCL-U有明显的区域分布特点，在欧美国家的发病率较低，而在我国及亚洲其他国家的发病率较高，约占T细胞淋巴瘤的50％，占非霍奇金淋巴瘤（non-Hodgkin＇s Lymphoma，NHL）的15％。
作者 郑文 朱军 谢彦 陆爱萍 王小沛 张运涛 涂梅峰 林宁晶 宋玉琴 平凌燕
机构地区 北京大学临床肿瘤学院 北京肿瘤医院暨北京市肿瘤防治研究所淋巴肿瘤科
出处 《中华肿瘤杂志》 CAS CSCD 北大核心 2008年第11期875-876,共2页 Chinese Journal of Oncology
关键词 非霍奇金淋巴瘤 T细胞淋巴瘤 诊断 治疗 non-Hodgkin＇s Lymphoma T-cell lymphoma Diagnosis Treatment
分类号 R686 [医药卫生—骨科学]
  • 相关文献

参考文献8

  • 1Arrowsmith ER, Macon WR, Kinney MC, et al. Peripheral T-cell lymphomas: clinical features and prognostic factors of 92 cases defined by the revised European American lymphoma classification. Leuk lymphoma, 2003, 44:241-249.
  • 2黄慧强,彭玉龙,林旭滨,孙晓菲,林桐榆,夏忠军,李宇红,蔡清清,何友兼,姜文奇,管忠震.CHOP方案治疗106例外周T细胞淋巴瘤的临床长期随访结果分析[J].癌症,2004,23(z1):1443-1447. 被引量：25
  • 3Tomita N, Motomura S, Hyo R, et al. Comparison of peripheral T-cell lymphomas and diffuse large B-cell lymphoma. Cancer, 2007, 109 : 1146-1151.
  • 4Chuang HC, Lay JD, Hsieh WC, et al. Pathogenesis and mechanism of disease progression from hemophagocytic lymphohistiocytosis to Epstein-Barr virus-associated T-cell lymphoma: nuclear factorkappa B pathway as a potential therapeutic target. Cancer Sci, 2007, 98 : 1281-1287.
  • 5Morabito F, Gallanmini A, Stelitano C, et al. Clinical relevance of immunophenotype in a retrospective comparative study of 297 peripheral T-cell lymphomas, unspecified, and 496 diffuse large B- cell lymphomas: experience of the Intergruppo Italiano Linformi. cancer, 2004, 101:1601-1608.
  • 6Karakas T, Bergmann L, Stutte HJ, et al. Peripheral T-cell lymphomas respond well to vincristine, adriamycin, cyclophosphamide, prednisone and etoposide (VACPE) and have a similar outcome as high-grade B-cell lymphoma. Leuk lymphoma, 1996, 24: 121- 129.
  • 7Fernandez HF, Escalon MP, Pereira D, et al. Autotransplant conditioning regimens for aggressive lymphoma: are we on the right mad? Bone Marrow Transplant, 2007, 40:505-513.
  • 8Savage KJ. Peripheral T-cell lymphomas. Blood Rev, 2007, 21 : 201-216.

二级参考文献13

  • 1[1]Kim K, Kim WS, Jung CW, et al. Clinical features of peripheral T-cell lymphomas in 78 patients diagnosed according to the REAL classification [J]. Eur J Cancer, 2002, 38 (1): 75 - 81.
  • 2[2]Edward R, Arrowsmit H, William R, et al. Peripheral T-cell Lymphomas: clinical features and prognostic factors of 92 cases defined by the Revised European American lymphoma classification [J]. Leuk Lymphoma, 2003, 44(2) :241 - 249.
  • 3[3]Gallamini A, Stelitano C, Calvi R, et al. Peripheral T-cell lymphoma unspecified(PTCL-U): a new prognostic model from a retrospective multicentric clinical study [J] . Blood, 2004, 103(7): 2474 - 2479.
  • 4[4]Rudiger T, Weisenburger DD, Anderson JR, et al. Peripheral T-cell lymphoma(excluding anaplastic large-cell lymphoma):results from the Non-Hodgkin's Lymphoma classification project [J].Ann Oncol, 2002, 13 ( 1 ): 140 - 149.
  • 5[5]Lee HK, Wilder RB, Jones D, et al. Outcomes using doxorubicin-based chemotherapy with or without radiotherapy for early-stage peripheral T-cell lymphomas [J]. Leu Lymphoma,2002, 43(9): 1769 - 1775.
  • 6[6]Pellatt J, Sweetenham J, Pickering RM, et al. A single-centre study of treatment outcomes and survival in 120 patients with peripheral T-cell non-Hodgkin's lymphoma [J]. Ann Hematol, 2002, 81 (5):267 - 272.
  • 7[7]Lopez-Guillermo A, Cid J, Salar A, et al. Peripheral T-cell lymphoma: initial features, natural history, and prognostic factors in a series of 174 patients diagnosed according to the REAL Classification [J]. Ann Oncol, 1998, 9(8): 849 - 855.
  • 8[8]Harris NL, Jaffe ES, Stein H, et al. A revised European-American classfication of Lmphoid neoplasms: a proposal from the international lymphoma study group [J]. Blood, 1994, 84(5):1361 - 1392.
  • 9[9]Zaja F, Russo D, Silvestri F, et al. Retrospective analysis of 23cases with peripheral T-cell lymphoma, unspecified: clinical characteristics and outcome [J]. Hematologica, 1997, 82(2):171 - 177.
  • 10[10]Liang R, Todd D, Chan TK, Chiu E, et al. Intensive chemotherapy for peripheral T-cell lymphomas. Hematol Oncol, 1992, 10(3 -4): 155 - 161.

共引文献24

同被引文献56

  • 1黄慧强,彭玉龙,林旭滨,孙晓菲,林桐榆,夏忠军,李宇红,蔡清清,何友兼,姜文奇,管忠震.CHOP方案治疗106例外周T细胞淋巴瘤的临床长期随访结果分析[J].癌症,2004,23(z1):1443-1447. 被引量：25
  • 2陆紫敏,朱海平,修冰,付建非,薄兰君,顾凤英.TCOP联合平阳霉素治疗中高度非霍奇金淋巴瘤的临床研究[J].中国肿瘤临床,2004,31(11):617-619. 被引量：6
  • 3彭玉龙,黄慧强,林旭滨,夏忠军,李宇红,王巍,何友兼,潘战和,姜文奇,管忠震.EPOCH方案治疗外周T细胞非霍奇金淋巴瘤的临床报告[J].癌症,2004,23(8):943-946. 被引量：11
  • 4吴颖,陈捷,田红,李莉莉.ATT方案治疗成熟外周T细胞淋巴瘤[J].南方医科大学学报,2006,26(5):638-639. 被引量：3
  • 5Rudiger T, Weisenburger DD, Anderson JR, et al. Peripheral T-cell lymphoma (excluding anaplastic large-cell lymphoma): results from the Non-Hodgkin's lymphoma classification project[J]. Ann Oncol, 2002, 13(1): 140-9.
  • 6Gallamini A, Stelitano C, Calvi R, et al. Peripheral T-cell lymphoma unspecified (PTCL-U): a new prognostic model from a retrospective multicentric clinical study [J]. Blood, 2004, 103(7): 2474-9.
  • 7Rizvi MA, Evens AM, Tallman MS, et al. T-cell non-Hodgkin lymphoma[J]. Blood, 2006, 107(4): 1255-64.
  • 8Lee Y, Uhm JE, Lee HY, et al. Clinical features and prognostic factors of patients with "peripheral T cell lymphoma, unspecified" iJ]. Ann Hematol, 2009, 88(2): 111-9.
  • 9Femandez HF, Escalon MP, Pereira D, et al. Autotransplant conditioning regimens for aggressive lymphoma: are we on the right road [J]? Bone Marrow Transplant, 2007, 40(6): 505-13.
  • 10Morton LM,Wang SS, Devesa SS, et al. Weisenburger DD and Linet MS:Lyrnphoma incidence patterns by WHO subtype in the United States-J]. Blood, 2006,107 (1) : 2665-2676.

引证文献5

二级引证文献8

中华肿瘤杂志
2008年 第11期

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部